| Biomarker ID | 441 |
| PMID | 19293807 |
| Year | 2009 |
| Biomarker | Ki-67 |
| Biomarker Basis | Expression Based |
| Biomolecule | Protein |
| Source | Tissue |
| Subjects | Humans |
| Regulation | Differentially Expressed [Cause Specific Survial (Δχ2 = 24.6) and overall survival (Δχ2 = 20.5)] |
| Odds Ratio/Hazard Ratio/Relative Risk | HR: 1.06 (95% CI:1.05 -1.07) |
| Effect on Pathways | Pathways Include:- RANKL regulation of apoptosis and immune response |
| Experiment | Overall Survival Vs No Survival |
| Type of Biomarker | Prognostic |
| Cohort | Cohort of 808 patients diagnosed with prostate cancer treated conservatively was included in the study, |
| Senstivity | NA |
| Specificity | NA |
| AUC | NA |
| Accuracy | NA |
| Level Of Significance | p<0.001 |
| Method Used | Immunohistochemistry |
| Clinical | No |
| Remarks | NA |
| Clinical Trial Number | NA |
| Degree Of Validity | Not validated on independent patient dataset |
| Technical Name | MKI67 |